-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QSzzjFjDSvtY+FDE22aEOKQQPXLZYMG7OqH3hMMjjZHIlv0ctOe9q1moYk9EurdA tRSqfVzVbcWcj6TrQyCS5Q== 0001367982-07-000104.txt : 20070302 0001367982-07-000104.hdr.sgml : 20070302 20070302171956 ACCESSION NUMBER: 0001367982-07-000104 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070228 FILED AS OF DATE: 20070302 DATE AS OF CHANGE: 20070302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYLIN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000881464 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330266089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195522200 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOLETTA MARK G CENTRAL INDEX KEY: 0001236389 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19700 FILM NUMBER: 07668809 BUSINESS ADDRESS: BUSINESS PHONE: 8585522200 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2007-02-28 0 0000881464 AMYLIN PHARMACEUTICALS INC AMLN 0001236389 FOLETTA MARK G 9360 TOWNE CENTRE DR SAN DIEGO CA 92121 0 1 0 0 Senior VP, Finance & CFO Common Stock 2007-02-28 4 A 0 232 33.0735 A 23242 D Common Stock 2007-02-28 4 M 0 14 11.95 A 23256 D Common Stock 2007-02-28 4 S 0 14 38.82 D 23242 D Common Stock 2007-02-28 4 M 0 2486 13.25 A 25728 D Common Stock 2007-02-28 4 S 0 2486 38.82 D 23242 D Incentive Stock Option (right to buy) 11.95 2007-02-28 4 M 0 14 0 D 2012-08-02 Common Stock 14 0 D Incentive Stock Option (right to buy) 13.25 2007-02-28 4 M 0 2486 0 D 2010-04-06 Common Stock 2486 24138 D Includes shares acquired through the Company's Employee Stock Purchase Plan. This sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. One-fourth (1/4) of this option grant vested on August 2, 2003 with the remainder of the grant vesting monthly over the next three years becoming fully-vested four years from the date of grant. One-fourth (1/4) of this option grant vested on April 6, 2001 with the remainder of the grant vesting daily over the next three years becoming fully-vested four years from the date of grant. By: /s/Darin M. Lippoldt, Attorney-in-Fact For: Mark G. Foletta 2007-03-02 -----END PRIVACY-ENHANCED MESSAGE-----